A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

TC Biopharm (Holdings) plc intends to begin proof-of-concept preclinical studies for its lead therapeutic TCB-008, to treat H5N1, or bird flu. TCB-008 is an allogeneic, unmodified cell therapy ...

Reaction formation is a defense mechanism in which people express the opposite of their true feelings, sometimes to an exaggerated extent. For instance, a man who feels insecure about his ...